What is the ideal combination therapy in de novo, oligometastatic, castration-sensitive prostate cancer?

Purpose To review current evidence regarding the management of de novo, oligometastatic, castration-sensitive prostate cancer (PCa). Methods A literature search was conducted on PubMed/Medline and a narrative synthesis of the evidence was performed in August 2022. Results Oligometastatic disease is...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of urology 2023-08, Vol.41 (8), p.2033-2041
Hauptverfasser:	Baboudjian, Michael, Roubaud, Guilhem, Fromont, Gaëlle, Gauthé, Mathieu, Beauval, Jean-Baptiste, Barret, Eric, Brureau, Laurent, Créhange, Gilles, Dariane, Charles, Fiard, Gaëlle, Mathieu, Romain, Ruffion, Alain, Rouprêt, Morgan, Renard-Penna, Raphaële, Sargos, Paul, Ploussard, Guillaume
Format:	Artikel
Sprache:	eng
Schlagworte:	Castration Combination therapy Life Sciences Medicine Medicine & Public Health Metastases Metastasis Nephrology Oncology Prostate cancer Prostatectomy Radiation therapy Topic Paper Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!